rezvilutamide

Key facts

Mechanism of action

Androgen Receptor antagonist

Primary target: Androgen receptor

Approval history

1. Rezvilutamide Phase 2 · Chinese Academy of · Metastatic Hormone-Sensitive Prostate Cancer
2. Rezvilutamide Phase 2 · Zenshine Pharmaceuticals · Prostate Cancer

1. bicalutamide Androgen Receptor antagonist
2. danazol Progesterone receptor agonist
3. nandrolone decanoate Androgen Receptor agonist
4. testosterone Genito-urinary system and sex hormones (G03)
5. testosterone cypionate Androgen Receptor agonist
6. apalutamide Antineoplastic and immunomodulating agents (L02)

Frequently asked questions